BCR and neoplasm: First, although inhibitors of BCR signalling (BCRi) undoubtedly have a major impact on the size of the leukemic clone, in many patients, small numbers of leukemic cells persist [9] suggesting that not all tumor cells are equally dependent on this pathway for survival.